Kestra Medical Technologies annual revenue
2023
2024
2025
2026
Kestra Medical Technologies reported $95.1M in revenue for fiscal 2026, an increase of 59.03% from the previous fiscal year.
View full Kestra Medical Technologies company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $95.1M | $35.3M | +59.03% |
| 2025 | 2025-04-30 | $59.8M | $32.0M | +115.05% |
| 2024 | 2024-04-30 | $27.8M | $20.2M | +264.53% |
| 2023 | 2023-04-30 | $7.6M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $28.6M | $11.4M | +66.18% |
| Q3 2026 | 2026-01-31 | $24.6M | $9.5M | +62.70% |
| Q2 2026 | 2025-10-31 | $22.6M | $7.9M | +53.40% |
| Q1 2026 | 2025-07-31 | $19.4M | $6.6M | +51.55% |
| Q4 2025 | 2025-04-30 | $17.2M | — | — |
| Q3 2025 | 2025-01-31 | $15.1M | — | — |
| Q2 2025 | 2024-10-31 | $14.7M | — | — |
| Q1 2025 | 2024-07-31 | $12.8M | — | — |
Kestra Medical Technologies's latest reported quarter, Q4 2026, generated $28.6M in revenue, an increase of 66.18% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Kestra Medical Technologies source filings ↗